ArticleCell communication and signaling : CCS2025

Targeting SHP2 to reverse immune evasion and resistance to anti-PD-1 therapy in non-small cell lung cancer.

Shiwei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.